Alzinova featured in Japanese media
Date: 2025-10-07
We’re pleased to share that Alzinova has been featured in a new Japanese article ahead of BioJapan 2025, where CEO Tord Labuda discusses our proprietary technology, the upcoming Phase II study, and our goal to develop the world’s first vaccine for Alzheimer’s disease. The article highlights ALZ-101’s unique oligomer-specific approach and Alzinova’s ambition to build strong international partnerships in the Alzheimer’s field.
